Dyadic International (OTCMKTS:DYAI) last released its quarterly earnings data on Thursday, August 10th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter. The firm had revenue of $0.21 million during the quarter. On average, analysts expect Dyadic International to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
COPYRIGHT VIOLATION NOTICE: “Dyadic International Inc. (DYAI) Set to Announce Quarterly Earnings on Thursday” was first posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.com-unik.info/2017/11/02/dyadic-international-inc-dyai-set-to-announce-quarterly-earnings-on-thursday.html.
Dyadic International Company Profile
Dyadic International, Inc (Dyadic) is a holding company. The Company is a global biotechnology company with operations in the United States and the Netherlands. Dyadic uses its technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzymes industries.
What are top analysts saying about Dyadic International Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Dyadic International Inc. and related companies.